Establishment and characterization of a human glioblastoma multiforme cell line

被引:12
作者
Bakir, A
Gezen, F
Yildiz, O [1 ]
Ayhan, A
Kahraman, S
Kruse, CA
Varella-Garcia, M
Yildiz, F
Kubar, A
机构
[1] Gulhane Sch Med, Dept Pharmacol, TR-06078 Ankara, Turkey
[2] Gulhane Sch Med, Dept Neurosurg, Ankara, Turkey
[3] Gulhane Sch Med, Dept Virol, Ankara, Turkey
[4] Hacettepe Sch Med, Dept Pathol, Ankara, Turkey
[5] Hacettepe Sch Med, Dept Radiat Oncol, Ankara, Turkey
[6] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Canc Ctr Cytogenet Core, Denver, CO USA
关键词
D O I
10.1016/S0165-4608(97)00364-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell lines provide a useful system for further understanding the biology of glioblastoma multiforme. In this study, a new glioblastoma multiforme cell line, GATAGM-96 (Gulhane Askeri Tip Akademisi-Glioblastoma Multiforme-96), was established from a tumor specimen removed from an 80-year-old male patient who underwent surgery for intracranial tumor. Morphologic examination, immunocytochemical staining, growth kinetics, and karyotypic characteristics of this cell line were studied. The cytoskeleton wets positive for neuron-specific enolase, vimentin, and neurofilament, and it was negative for glial fibrillary acidic protein, S-100 protein, p53 protein, epidermal growth factor, and transforming growth factor cc. Growth kinetic studies demonstrated an approximate population doubling time of 38 to 42 h and a colony forming efficiency of 83.3%. The karyotype of the cells demonstrated it as hyperdiploid, with a large subpopulation of polyploid cells. There were numerous structural and numerical chromosome aberrations; most of them were present as clonal events. The phenotypic and chromosomal features detailed on the GATAGM-96 cell line should make it a useful addition to the cell lines currently available for in vitro and in vivo studies of glioblastoma multiforme. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 38 条
[1]  
Albarosa R, 1996, AM J HUM GENET, V58, P1260
[2]   P53-PROTEIN ACCUMULATION AND GENE-MUTATIONS IN HUMAN GLIOMA CELL-LINES [J].
ANKER, L ;
OHGAKI, H ;
LUDEKE, BI ;
HERRMANN, HD ;
KLEIHUES, P ;
WESTPHAL, M .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (06) :982-987
[3]  
AYHAN A, 1992, INT J ONCOL, V1, P431
[4]  
BACCIOCCHI G, 1992, ANTICANCER RES, V12, P853
[5]   TRISOMY-7 IN NONNEOPLASTIC FOCAL STEATOSIS OF THE LIVER [J].
BARDI, G ;
JOHANSSON, B ;
PANDIS, N ;
HEIM, S ;
MANDAHL, N ;
HAGERSTRAND, I ;
HOLMIN, T ;
ANDRENSANDBERG, A ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1992, 63 (01) :22-24
[6]  
BELLO MJ, 1994, GENE CHROMOSOME CANC, V9, P33
[7]   HETEROGENEITY OF GENOTYPIC AND PHENOTYPIC CHARACTERISTICS OF 15 PERMANENT CELL-LINES DERIVED FROM HUMAN GLIOMAS [J].
BIGNER, DD ;
BIGNER, SH ;
PONTEN, J ;
WESTERMARK, B ;
MAHALEY, MS ;
RUOSLAHTI, E ;
HERSCHMAN, H ;
ENG, LF ;
WIKSTRAND, CJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1981, 40 (03) :201-229
[8]  
BIGNER SH, 1988, CANCER RES, V48, P405
[9]   CYTOGENETICS OF HUMAN BRAIN-TUMORS [J].
BIGNER, SH ;
MARK, J ;
BIGNER, DD .
CANCER GENETICS AND CYTOGENETICS, 1990, 47 (02) :141-154
[10]   CHANGES IN GLIAL FIBRILLARY ACIDIC PROTEIN AND KARYOTYPE DURING CULTURING OF 2 CELL-LINES ESTABLISHED FROM HUMAN GLIOBLASTOMA-MULTIFORME [J].
BOCCHINI, V ;
CASALONE, R ;
COLLINI, P ;
REBEL, G ;
LOCURTO, F .
CELL AND TISSUE RESEARCH, 1991, 265 (01) :73-81